highest sixes in all format Five aspects of in-depth understanding of the next steps in medical reform? INOVIO to Release Data from DNA Therapy Combined with PD-1 Inhibitors for GBM Pfizer's XELJANZ ...
The management of rheumatoid arthritis has seen tremendous changes over the past 25 years, since the increasing availability of biological disease-modifying antirheumatic drugs (DMARDs) with various ...
Celltrion today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted positive opinions and recommended marketing authorisations ...
ANB032 was well tolerated across all doses with no safety signals observed; AD trial and all further investment in ANB032 will be discontinued; Anticipate top-line Phase 2b data i ...